Cytori Therapeutics Inc. elected Ronald Martell as an independent board member, effective Dec. 27.
Martell was previously the CEO of Sevion Therapeutics Inc.
Cytori elects former Sevion Therapeutics CEO to board
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Commercial Banking Newsletter June Edition - 2022
Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push
Cytori Therapeutics Inc. elected Ronald Martell as an independent board member, effective Dec. 27.
Martell was previously the CEO of Sevion Therapeutics Inc.